166 related articles for article (PubMed ID: 29526962)
21. Primary cutaneous CD8+ cytotoxic T-cell lymphoma involving the epidermis and subcutis in a young child.
Wang L; Gao T; Wang G
J Cutan Pathol; 2015 Apr; 42(4):271-5. PubMed ID: 25458991
[TBL] [Abstract][Full Text] [Related]
22. Transplantation in the Treatment of Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8-Positive T-Cell Lymphoma.
Cyrenne BM; Gibson JF; Subtil A; Girardi M; Isufi I; Seropian S; Foss F
Clin Lymphoma Myeloma Leuk; 2018 Jan; 18(1):e85-e93. PubMed ID: 29223388
[TBL] [Abstract][Full Text] [Related]
23. Durable remission of a patient with primary cutaneous CD8
Al Aoun SM; Iqbal S; AlHalouli TM; Zaidi SZ; Motabi IH
Hematol Oncol Stem Cell Ther; 2021 Mar; 14(1):71-75. PubMed ID: 30291826
[TBL] [Abstract][Full Text] [Related]
24. Epidermotropic CD8+ cytotoxic T-cell lymphoma exhibiting a transition from the indolent to the aggressive phase, accompanied by emergence of CD7+ cells and formation of neutrophilic pustules.
Ito Y; Goto M; Hatano Y; Kawamoto M; Ohishi M; Takayasu S; Katagiri K; Fujiwara S
Clin Exp Dermatol; 2012 Mar; 37(2):128-31. PubMed ID: 21883402
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous CD8+ T-cell lymphoma masquerading as acral vascular syndrome.
Le Loarer F; Barete S; Vallat L; Carre D; El Amarti R; Torres-Cabala C; Cacoub P; Sene D; Courville P; Bravard P
Acta Derm Venereol; 2014 May; 94(3):317-9. PubMed ID: 23995595
[No Abstract] [Full Text] [Related]
26. Primary cutaneous aggressive epidermotropic CD8+ T cell lymphoma with a chronic and indolent course. Is this different from peripheral T cell lymphoma?
Gomez Vazquez M; Navarra Amayuelas R
Dermatol Online J; 2012 Mar; 18(3):11. PubMed ID: 22483522
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
Berti E; Tomasini D; Vermeer MH; Meijer CJ; Alessi E; Willemze R
Am J Pathol; 1999 Aug; 155(2):483-92. PubMed ID: 10433941
[TBL] [Abstract][Full Text] [Related]
28. Aggressive epidermotropic cutaneous CD8+ lymphoma.
DI Meo N; Stinco G; Trevisini S; Croatto M; Trevisan G
G Ital Dermatol Venereol; 2016 Dec; 151(6):730-732. PubMed ID: 27824230
[No Abstract] [Full Text] [Related]
29. Primary cutaneous CD8
Wei R; Wang H; Zhang J; Zhang Z; Yao Z
Int J Dermatol; 2024 May; 63(5):660-663. PubMed ID: 38263572
[No Abstract] [Full Text] [Related]
30. Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: transformation from indolent to aggressive phase in association with CCR7-positive conversion.
Kasuya A; Hirakawa S; Tokura Y
Dermatol Online J; 2012 Oct; 18(10):5. PubMed ID: 23122012
[TBL] [Abstract][Full Text] [Related]
31. [Unusual course of CD8+ epidermotropic cutaneous T-cell lymphoma].
Gardette E; Moguelet P; Barete S; Frances C; Senet P
Ann Dermatol Venereol; 2016 Dec; 143(12):846-851. PubMed ID: 27161647
[TBL] [Abstract][Full Text] [Related]
32. Erythema multiforme-like lesions in primary cutaneous aggressive cytotoxic epidermotropic CD8+ T-cell lymphoma: A diagnostic and therapeutic challenge.
Tomasini C; Novelli M; Fanoni D; Berti EF
J Cutan Pathol; 2017 Oct; 44(10):867-873. PubMed ID: 28644551
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood flow cytometry based diagnosis in primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: implications for more extensive use.
Benetatos L; Dova L; Baxevanos G; Kolaitis NI; Bourantas KL; Vartholomatos G
Cytometry B Clin Cytom; 2009 Mar; 76(2):102-6. PubMed ID: 18956469
[TBL] [Abstract][Full Text] [Related]
34. Indolent CD8-positive T-cell lymphoid proliferation of the ear: a report of two cases.
Zeng W; Nava VE; Cohen P; Ozdemirli M
J Cutan Pathol; 2012 Jul; 39(7):696-700. PubMed ID: 22612273
[TBL] [Abstract][Full Text] [Related]
35. CD8-positive mycosis fungoides and primary cutaneous aggressive epidermotropic CD8-positive cytotoxic T-cell lymphoma.
Diwan H; Ivan D
J Cutan Pathol; 2009 Mar; 36(3):390-2. PubMed ID: 19220641
[No Abstract] [Full Text] [Related]
36. Fatal Case of Primary Cutaneous Aggressive T-Cell Lymphoma Switching From a CD4+ to a CD8+ Phenotype: Progressive Disease With Bexarotene and Romidepsin Treatment.
Johnson WT; Leeman-Neill RJ; Patel P; Ho J; Grandinetti LM; Jedrych J; Craig FE
Am J Dermatopathol; 2016 Nov; 38(11):832-837. PubMed ID: 27322928
[TBL] [Abstract][Full Text] [Related]
37. Transformation of lymphomatoid papulosis type D to CD8-positive aggressive epidermotropic cytotoxic T-cell lymphoma.
Gill P; Chia J; Street L; Mahe E
Histopathology; 2021 Sep; 79(3):442-444. PubMed ID: 34050974
[No Abstract] [Full Text] [Related]
38. Primary cutaneous CD8+ aggressive epidermotropic T-cell lymphoma mimicking pyoderma gangrenosum.
Flora A; Gibson M; Toon C; Rawson R; Lowe P
Indian J Dermatol Venereol Leprol; 2021; 88(1):90-92. PubMed ID: 34951938
[No Abstract] [Full Text] [Related]
39. Primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma resembling pemphigus vulgaris.
Gilkey TW; Pettit C; Korman A; Plaza JA; Trinidad J
Int J Dermatol; 2022 Oct; 61(10):1298-1300. PubMed ID: 34633071
[No Abstract] [Full Text] [Related]
40. Primary cutaneous aggressive epidermotropic CD8 + T-cell lymphoma on upper eyelid.
Lee J; Yang YJ; Kim JI; Park JH; Kim WS
Indian J Ophthalmol; 2015 Jan; 63(1):81-2. PubMed ID: 25686076
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
